Literature DB >> 14599344

Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.

Anna-Rebekka Ressmeyer1, Juan C Mayo, Veronika Zelosko, Rosa M Sáinz, Dun-Xian Tan, Burkhard Poeggeler, Isaac Antolín, Beata K Zsizsik, Russel J Reiter, Rüdiger Hardeland.   

Abstract

In numerous experimental systems, the neurohormone melatonin has been shown to protect against oxidative stress, an effect which appears to be the result of a combination of different actions. In this study, we have investigated the possible contribution to radical scavenging by substituted kynuramines formed from melatonin via pyrrole ring cleavage. N1-Acetyl-5-methoxykynuramine (AMK), a metabolite deriving from melatonin by mechanisms involving free radicals, exhibits potent antioxidant properties exceeding those of its direct precursor N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and its analog N1-acetylkynuramine (AK). Scavenging of hydroxyl radicals was demonstrated by competition with ABTS in a Fenton reaction system at pH 5 and by competition with DMSO in a hemin-catalyzed H2O2 system at pH 8. Under catalysis by hemin, oxidation of AMK was accompanied by the emission of chemiluminescence. AMK was a potent reductant of ABTS cation radicals, but, in the absence of catalysts, a poor scavenger of superoxide anions. In accordance with the latter observation, AMK was fairly stable in a pH 8 H2O2 system devoid of hemin. Contrary to AFMK, AMK was easily oxidized in a reaction mixture generating carbonate radicals. In an oxidative protein destruction assay based on peroxyl radical formation, AMK proved to be highly protective. No prooxidant properties of AMK were detected in a sensitive biological test system based on light emission by the bioluminescent dinoflagellate Lingulodinium polyedrum. AMK may contribute to the antioxidant properties of the indolic precursor melatonin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599344     DOI: 10.1179/135100003225002709

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  48 in total

1.  Urinary metabolites and antioxidant products of exogenous melatonin in the mouse.

Authors:  Xiaochao Ma; Jeffrey R Idle; Kristopher W Krausz; Dun-Xian Tan; Leopoldo Ceraulo; Frank J Gonzalez
Journal:  J Pineal Res       Date:  2006-05       Impact factor: 13.007

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 3.  Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Luis C López; Ana B Hitos; Josefa León
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

4.  General anesthesia for surgery influences melatonin and cortisol levels.

Authors:  Edward Ram; Tali H Vishne; Talia Weinstein; Benzion Beilin; Zeev Dreznik
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

Review 5.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

Review 6.  Melatonin transport into mitochondria.

Authors:  Juan C Mayo; Rosa M Sainz; Pedro González-Menéndez; David Hevia; Rafael Cernuda-Cernuda
Journal:  Cell Mol Life Sci       Date:  2017-08-21       Impact factor: 9.261

Review 7.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 8.  Measurement of melatonin and its metabolites: importance for the evaluation of their biological roles.

Authors:  Glaucia R Martinez; Eduardo A Almeida; Clécio F Klitzke; Janice Onuki; Fernanda M Prado; Marisa H G Medeiros; Paolo Di Mascio
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 9.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

10.  Comparative effects of melatonin and vitamin E in restoring aortic relaxation in pancreatectomized rats.

Authors:  C F Reyes-Toso; L M Linares; L E Albornoz; D Obaya-Naredo; M L Wallinger; C R Ricci; D P Cardinali
Journal:  J Physiol Biochem       Date:  2006-09       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.